Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
Clinical trial NCT07215637 · RECRUITING
Trial details
- NCT number
- NCT07215637
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-16
- Primary completion
- 2027-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.